Scilex Holding Company Announces The State Of Indiana Medicaid Will Add Elyxyb As A Preferred Agent To Its Preferred Drug List Effective Oct. 1, 2023
Portfolio Pulse from Benzinga Newsdesk
Scilex Holding Company announced that the State of Indiana Medicaid will add Elyxyb, a drug developed by the company, to its Preferred Drug List effective from October 1, 2023.
September 25, 2023 | 1:03 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Scilex's drug Elyxyb will be added to Indiana Medicaid's Preferred Drug List, potentially increasing the company's market reach and revenues.
The inclusion of Elyxyb in the Preferred Drug List of Indiana Medicaid implies that the drug will be more accessible to a larger patient population. This could lead to increased sales and revenues for Scilex, positively impacting its stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100